Our calendar informs on industry events, upcoming compliance deadlines, as well as new Obelis webinars.
Canada - Fragrance Allergen Disclosure Deadline ✅12 April 2026: New and existing cosmetics have to disclose the 24 fragrance allergens listed below within the list of ingredients, when present at concentration greater than 0.01% in rinse-off products and 0.001% in leave-on products. To ensure compliance with the above regulatory changes, we recommend reviewing and, where…
Making plans to attend Interclean Amsterdam? This April, the world’s leading cleaning and hygiene event returns to the RAI Amsterdam with an expanded show floor and more international exhibitors. Interclean Amsterdam is the premier stage for the professional cleaning industry and Obelis Group is proud to be part of the movement. At Obelis, we help…
2026 is a critical year for cosmetic compliance - and the Responsible Technical Person is at the center of it.Join our 60-minute LIVE webinar to discover how to safeguard your products, avoid regulatory risks, and implement GMP with ISO 22716. ✅ GMP Essentials: key principles for cosmetic products✅ RTP Responsibilities: legal and operational must-knows✅ Practical Tips: ensure compliance efficiently✅ Expert Insights: from Sandra Ferretti, CCO at Obelis Group, and Selim Erol,…
Get a clear and practical overview of the essential rules governing food supplements in the EU and UK. This on-demand webinar walks you through the core legislation and compliance requirements every Food Business Operator (FBO) must know.Webinar highlights :✅ Regulation (EC) 178/2002 – General Food Law✅ Brexit and its impact on labeling & notifications✅ Compliance challenges when selling…
European Union - Omnibus Act VIII amends the Cosmetic Regulations ✅1 May 2026: Products containing 3-(4′-methylbenzylidene)-camphor (CAS No 36861-47-9/38102-62-4) can no longer be made available on the market. ✅1 May 2026: With no distinction between placing products on the market and making them available, Omnibus Act VIII will apply. This means that, from the application date, non-compliant cosmetics can…
Heading to GITEX Future Health Africa?As Africa’s leading platform for health innovation and policy, GITEX Future Health Africa is where healthcare’s evolution meets the continent's digital future. Obelis Group is more than excited to be a part of this transformative event in Morocco this May. In an era where AI and deep tech are reimagining…
Keen on Beauty Care? Let's meet at Beauty Istanbul, one of the largest cosmetics exhibitions worldwide! Our Mission? Helping cosmetics brands seamlessly adapt to global compliance standards.Why Meet Us at Beauty Istanbul?✅ Expert insights on market access & compliance✅ Tailored strategies to accelerate approvals✅ Guidance on the latest regulatory updatesLet’s connect to discuss how we can…
As the transition to the In Vitro Diagnostic Regulation (IVDR) continues, we would like to remind you of the critical 2026 deadlines for legacy IVDs that are classified to Class C under IVDR. For these devices, the following milestones apply: ✅A written agreement between the manufacturer and the Notified Body must be signed by 26 September 2026. ✅The manufacturer or their Authorised…
Regulatory Alert | EUDAMED becomes mandatory Commission Decision (EU) 2025/2371 confirms the full functionality of the first four EUDAMED modules. As a result, economic operators must comply with mandatory registration requirements. Mandatory modules from 28 May 2026: ✅Market Surveillance ✅Actors: registration of manufacturers, authorised representatives, importers ✅UDI / Devices: device registration (excluding custom-made devices) ✅Notified Bodies &…